Skip to main content
. 2023 Mar 20;11(3):950. doi: 10.3390/biomedicines11030950

Table 5.

Amivantamab-vmjw Dose Reduction Levels for Adverse Reactions [15].

Body Weight at Baseline Dose Level Dose
Less than 80 kg 0 1050 mg
−1 700 mg
−2 350 mg
Greater than or equal to 80 kg −3
0
−1
−2
−3
Discontinue
1400 mg
1050 mg
700 mg
Discontinue